BBVA USA’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
Other funds holding ZBH
BBVA USA's ZBH Position: Q3 2021 in Review
BBVA USA reduced its Zimmer Biomet (ZBH) stake by 13% in Q3 2021, selling an estimated $7.65K and leaving 350 shares worth $50K. The position accounts for ﹤0.01% of the portfolio, ranked #657.
BBVA USA first reported a position in ZBH in Q2 2021 and has held it in 2 quarters since. The position peaked at $63K in Q2 2021. 982 funds tracked by Wall St. Rank hold ZBH as of Q3 2021.
- BBVA USA held 350 shares of Zimmer Biomet worth $50K as of Q3 2021.
- BBVA USA sold 52 Zimmer Biomet shares in Q3 2021, an estimated $7.65K.
- Zimmer Biomet made up ﹤0.01% of BBVA USA's portfolio in Q3 2021, its #657 holding.
- BBVA USA first reported a position in Zimmer Biomet in Q2 2021 and has held it in 2 quarters since.
- BBVA USA's Zimmer Biomet position peaked at $63K in Q2 2021.
- 982 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2021.
Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.